Position in URGN
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$2,021,129
+$1,132,792 QoQ
Shares Held
54,922
+11.2% QoQ
Ownership
0.112%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#59
of 190 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 22%
Shared 0%
None 78%
Common Shares in URGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RHUMBLINE ADVISERS holds $1,414,750,230 across 329 Biotechnology names. URGN ranks #99 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
396,380 | $196,893,837 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,794 | $98,390,870 | |
| 3 | MRNA |
Moderna, Inc.
|
809,853 | $56,714,005 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
165,579 | $49,844,246 | |
| 5 | INCY |
Incyte Corp
|
428,533 | $48,578,500 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
226,008 | $42,326,778 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
1,178,789 | $41,717,342 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
163,018 | $39,282,447 |
All Filings in URGN
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,021,129 | 54,922 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $888,337 | 49,407 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $1,071,699 | 45,760 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,016,512 | 50,953 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $702,714 | 51,293 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $591,333 | 53,466 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $546,025 | 51,270 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $633,323 | 49,868 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $847,004 | 50,477 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $551,940 | 36,796 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $520,590 | 34,706 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $376,364 | 26,864 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $211,202 | 20,406 | Shares | Sole | 2023-08-08 | |
| 2022-03-31 | $201,653 | 23,152 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $228,848 | 24,064 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $410,542 | 24,408 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $364,998 | 23,903 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $517,739 | 26,578 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $516,236 | 28,648 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $492,222 | 25,517 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $759,752 | 29,087 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $420,096 | 23,548 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||